iiinova — where your digital self keeps evolving

Reposted by @natalie-mccor.bsky.social

Dr. John Cush @rheumnow.bsky.social · 28/07/2026

Evidence-Based Dietary Recommendations for Gout buff.ly/EloVYWN

011

Reposted by @natalie-mccor.bsky.social

ACR Journals @acr-journals.bsky.social · 13/05/2026

Population-based study of ED visits for gout in Ontario, Canada 2014-2023 showed low use of gout-specific follow-up visits (21%) and high opioid prescriptions (10%). Within 90-days, 30% had repeat ED/acute care visit, 9.4% specifically for gout Arthritis Care & Research doi.org/10.1002/acr....

011

Reposted by @natalie-mccor.bsky.social

Arthritis Research Canada @arthritisresearch.bsky.social · 17/04/2026

We are excited to share executive summaries of the research abstracts that Arthritis Research Canada scientists & trainees are presenting at the 2026 Canadian Rheumatology Association Scientific Meeting. Check out our presentations here: ow.ly/9ckM50YKJiJ

ow.ly

CRA Annual Scientific Meeting 2026 - Day 1: April 17 - Arthritis Research Canada

Learn about the arthritis research our scientists are presenting at the 2026 CRA & AHPA Annual Scientific Meeting.

101

Reposted by @natalie-mccor.bsky.social

GUCDD MDPI @gucddmdpi.bsky.social · 15/04/2026

📢 Don’t forget to apply! 🏆The Best PhD Thesis Award is still open for applications. 🎁 CHF 1000 📅 Deadline: 31 May 2026 🎓 PhD (2025) in #Gout #Urate or #Crystaldepositiondisease For more information: www.mdpi.com/journal/gucd... #BestPhDThesisAward

011

Reposted by @natalie-mccor.bsky.social

GUCDD MDPI @gucddmdpi.bsky.social · 07/04/2026

📢 We are pleased to share that the GUCDD will be exhibiting at the 28th Asia-Pacific League of Associations for #Rheumatology Congress, which will be held from 28 October to 1 November 2026 in Seoul, Republic of Korea. 👉 Meet us at booth 17! 🔗Find out more at: www.mdpi.com/about/announ...

021

Reposted by @natalie-mccor.bsky.social

CATA @arthritistrainees.bsky.social · 20/03/2026

Meet our panelist! Dr. Clare Ardern is an assistant professor in the Department of Physical Therapy at The University of British Columbia Learn more about her career trajectory at CATA’s careers panel on March 24th, 9:00 AM PST/12:00 PM EST 🎟️Register here: forms.gle/PiJhriNQHcEK...

021

Reposted by @natalie-mccor.bsky.social

CATA @arthritistrainees.bsky.social · 18/03/2026

Meet our panelist! Dr. Antoine Dufour is an Associate Professor in the Department of Physiology and Pharmacology at the University of Calgary Learn more about his career trajectory at CATA’s careers panel on March 24th, 9:00 AM PST/12:00 PM EST 🎟️Register here: forms.gle/PiJhriNQHcEK...

021

Reposted by @natalie-mccor.bsky.social

GUCDD MDPI @gucddmdpi.bsky.social · 16/03/2026

📌Newly published paper! 📝 Non-Hyperuricemia Experimental Models of Gout! 👥 Authors: Yevetta Xiang, An-Tzu Chien, and Christopher Hall 🔗 Full article: www.mdpi.com/2813-4583/4/...

mdpi.com

011

Reposted by @natalie-mccor.bsky.social

CATA @arthritistrainees.bsky.social · 16/03/2026

Meet our panelist! Dr. Ingrid Goh is a Senior Research Associate in the Feldman Lab at The Hospital for Sick Children in Toronto Learn more about her career trajectory at CATA’s careers panel on March 24th, 9:00 AM PST/12:00 PM EST 🎟️Register here: forms.gle/PiJhriNQHcEK...

011

Reposted by @natalie-mccor.bsky.social

CATA @arthritistrainees.bsky.social · 13/03/2026

🚀 Looking for different opportunities in arthritis research? CATA will host a career panel where guest speakers will share insights, career journeys, and advice for arthritis trainees 📅 March 24th, 12-1pm ET 🎟️ Register: forms.gle/PiJhriNQHcEK... #Arthritis #Research #PhD #PostDoc #Academic #CATA

forms.gle

Canadian Arthritis Trainee Association (CATA) Career Panel - March 2026

Join the CATA for an engaging career panel on Tuesday March 24th, 12-1pm ET. Our guest speakers will share their career journeys, insights into research in academic and clinical settings, and advice f...

011

Reposted by @natalie-mccor.bsky.social

CATA @arthritistrainees.bsky.social · 03/03/2026

Not sure what lies ahead after your grad studies or post-doc? Want to learn more about different opportunities in arthritis research? Join us for the CATA's Academic Careers Panel 📅 March 24th, 12-1pm ET 🎟️ Register: forms.gle/PiJhriNQHcEK... #Arthritis #Research #CATA #PhD #Postdoc

031

Reposted by @natalie-mccor.bsky.social

GUCDD MDPI @gucddmdpi.bsky.social · 02/03/2026

📝 #Allopurinol-Related Severe Cutaneous Adverse Reactions: A Narrative Review! 👥 Authors: Edoardo Cipolletta, Satveer K. Mahil, Catherine H. Smith and Abhishek Abhishek 🔗 Read the full article here: www.mdpi.com/2813-4583/4/...

mdpi.com

011

Reposted by @natalie-mccor.bsky.social

ACR Journals @acr-journals.bsky.social · 10/07/2025

Higher intakes of lignans matairesinol & secoisolariciresinol were significantly assoc. w/ lower gout risk. Selected whole grain foods rich in lignans, including whole grain cold cereals & cooked oatmeal/oat bran were also inversely assoc. w/ incident gout AC&R doi.org/10.1002/acr.... #Medsky

Age-adjusted Spearman correlation coefficients between lignan intake and individual dietary factors in the Health Professionals Follow-up Study (HPFS; panel A) over the follow-up

Age-adjusted Spearman correlation coefficients between lignan intake and individual dietary factors in the Nurses’ Health Study (NHS; panel B) over the follow-up

011

Reposted by @natalie-mccor.bsky.social

GUCDD MDPI @gucddmdpi.bsky.social · 02/07/2025

🏆 Winner Announcement 🏆 We’re excited to share that Dr. Tom Niessink has won the GUCDD Best PhD Thesis Award! 🎓👏 🎉 Congrats, Dr. Niessink! 🔗 Learn more: www.mdpi.com/journal/gucd... #PhDthesisaward #rheumatology #gout

011

Reposted by @natalie-mccor.bsky.social

ACR Journals @acr-journals.bsky.social · 03/06/2025

Target trial emulations compared CV safety of NSAIDs vs colchicine among patients with gout starting allopurinol, and found NSAID prophylaxis was associated with higher risk of CV events than colchicine or no prophylaxis Arthritis & Rheumatology doi.org/10.1002/art.... #Medsky #Rheumsky

Risk of Primary and Secondary Outcomes with NSAIDs versus Colchicine, Propensity Score-Matching (Top) and Inverse Probability of Treatment Weighting (Bottom)

052